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Abstract: Bioresorbable scaffolds made of poly(L-lactic acid)
(PLA) obtained by supercritical gas foaming were recently
described as suitable for tissue engineering, portraying bio-
compatibility with primary osteoblasts in vitro and interesting
mechanical properties when reinforced with ceramics. The
behavior of such constructs remained to be evaluated in vivo
and therefore the present study was undertaken to compare
different PLA/ceramic composite scaffolds obtained by
supercritical gas foaming in a critical size defect craniotomy
model in Sprague–Dawley rats. The host-tissue reaction to
the implants was evaluated semiquantitatively and similar
tendencies were noted for all graft substitutes: initially highly
reactive but decreasing with time implanted. Complete bone-
bridging was observed 18 weeks after implantation with
PLA/ 5 wt % b-TCP (PLA/TCP) and PLA/5 wt % HA
(PLA/HA) scaffolds as assessed by histology and radiogra-
phy. We show here for the first time that this solvent-free
technique provides a promising approach in tissue engineer-
ing demonstrating both the biocompatibility and osteocon-
ductivity of the processed structures in vivo. ! 2007 Wiley
Periodicals, Inc. J BiomedMater Res 83A: 41–51, 2007
Key words: bone tissue engineering; biomaterials; biocom-
patibility; scaffold; polylactic acid
INTRODUCTION
Ceramic-reinforced poly(L-lactic acid) (PLA) struc-
tures obtained by melt-extrusion followed by super-
critical gas foaming offer suitable conditions for
primary human fetal osteoblasts to achieve a full
differentiation process in vitro.1 Therefore, it was of
interest to look at in vivo host-tissue induced reac-
tions as well as the potential for osteoconductive
properties of these biomaterials. As maxillofacial
bone repair is one of the targeted applications for
the implants described here, they were tested pre-
clinically in a cranial model.
The critical size defect model (CSD) is often used
to study orthopaedic materials.2 It has been defined
as the smallest in situ bone defect that could not heal
spontaneously by bone formation during the lifespan
of the animal.3 The CSD created on the bony vault
of the cranium (calvaria) represents a severe test for
bone graft substitutes.3 Compared with long bones,
the skull is biologically rather inert due to a poor
blood supply and a relative deficiency of bone
marrow.4 CSDs in the calvaria have been established
for different animal species.4–20 The rat calvarial
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model offers advantages: the parietal bone is a large
plate that facilitates the operation and the analysis
(histology, imaging), no implant fixation is required,
and the costs are limited in comparison with large
animal models. Furthermore, as this experimental
approach is widely used, a precise comparison of
different grafted materials is possible.21 Modeling on
parietal bone has been applied to rats from different
strains and at various ages.7–9,22,23 The Sprague–
Dawley rats used herein did not spontaneously fill
8 mm diameter full thickness defects 12-weeks post-
surgery.24
Different types of bone graft substitutes can be
used to fill a CSD. Among them, synthetic substitutes
are generally made of ceramics, such as calcium
phosphate, or polymers, such as collagen or poly(a-
hydroxy acids). However, ceramics tend to be too
brittle and polymers too soft. Working with polymer-
based composites offers a wider range of mechanical
properties closer to bone, osteocondution induced by
ceramics and a better control of resorption rate.25–27
Polymer-based foams can be processed in different
ways: solvent casting/particulate leaching,28,29 ther-
mally induced phase separation, or emulsion freeze-
drying,30–33 gas foaming.34–36 The latter technique
has the main advantage of avoiding the use of poten-
tially toxic organic solvents.37 Gas foaming is based
on the use of a gas porogen, and can be decomposed
into several steps: gas dissolution, bubble nucleation,
growth, and stabilization. Every step affects final
foam morphology: controlling saturation pressure
monitors gas concentration in the polymer and there-
fore porosity volume. The rate of pressure release
influences pore nucleation density; the rate of tem-
perature decrease governs pore growth, therefore
pore diameter and interconnections. Use of supercrit-
ical CO2 allows the incorporation of biological agents
and ceramic particles, and the manufacture of open
pore foams with low intrinsic viscosity amorphous
PLGA (polylactic-co-glycolic acid).38–40 In this study
we focused on semicrystalline PLA, which allowed
us obtaining open pore scaffolds with controlled po-
rosity and morphology and improved mechanical
properties, thus creating for bone cells an environ-
ment similar to natural bone.
Therefore, PLA/5 wt % b-TCP (PLA/TCP) and
PLA/5 wt % HA (PLA/HA) implants were tested in
the Sprague–Dawley CSD craniotomy model to
determine their interactions with host tissues and
their osteoconductive abilities. Comparison was
extended to b-tricalcium phosphate matrix (hereafter
designated as b-TCP Mathys), with the same compo-
sition and structure like chronOSTM scaffolds already
used in clinical applications (Synthes, Bettlach, Swit-
zerland). We demonstrate here, for the first time, the
high osteoconductive potential of PLA/ceramic com-
posite structures processed by supercritical gas
foaming. Thus, this original approach is undoubt-
edly promising for bone tissue engineering.
MATERIALS AND METHODS
Animals and housing
All animal experiments were performed with the ap-
proval of the Veterinary Authority from the Canton of
Vaud (authorization No. 1777). Sprague–Dawley albino
rats (females, 84–92 days old, 275–300 g) were purchased
from Iffa Credo (Charles River Laboratories, L’Arbresle
Cedex, France) and acclimated for 14 days prior to sur-
gery. Animals were grouped by 3 on wood-based litters in
PET cages (405 3 255 3 197 mm3) equipped with Reemay
filter covers (No. E4FVCOU910, Charles River Laborato-
ries, L’Arbresle Cedex, France). Strictly controlled breeding
conditions were used: temperature: (22 6 2)8C, relative hu-
midity: (55 6 10)%, light/dark hours schedule : 12/12.
They were fed a balanced solid diet (Mouse/Rat – com-
plete feed extrudate 3436, Provimi Kibla AG, Switzerland)
with food and water provided ad libitum during the experi-
ment. Individual body weights were recorded prior to im-
plantation and thereafter on a weekly basis.
Scaffold generation
Processing of the foams, and analyses of the scaffold
morphology and properties were published in details else-
where.41 A PLA (Boehringher Ingelheim, Germany) and
two ceramic powders, hydroxyapatite (HA) (Merck KGaA,
Darmstadt, Germany) and b-tricalcium phosphate (b-TCP)
(Fluka, Buchs SG, Switzerland), were included in this
study. The batch of HA (nano) powder used hereafter was
recently described.42 Its purity was verified by X-ray dif-
fraction (XRD) and its size assessed by measuring its spe-
cific surface area (SSA) that was 62.53 m2/g (standard
deviation (SD) ¼ 0.20 m2/g). The b-TCP (micro) powder
was usually shown by XRD to contain small amounts of b-
calcium pyrophosphate (b-CPP, max < 10%). A represen-
tative measured SSA for this powder was 1.10 m2/g (SD ¼
0.01 m2/g). Scaffolds were generated as following: after
drying, PLA pellets and ceramic particles (5 wt %) were
mixed, and further melt-extruded in order to obtain cohe-
sive composite preforms. Mixing parameters of the micro-
compounder (Micro 5, DSM, The Netherlands) were set at
a temperature of 2058C, a screw rotation speed of 100 rpm,
and a residence time of 4 min.43 Foaming was then carried
out using supercritical CO2 (pure >99.995%; SL Gas, Swit-
zerland) in a custom made high-pressure chamber (Auto-
clave France, France), equipped with a computerized data
acquisition system. After polymer saturation with CO2,
foaming was achieved by sudden gas release and the po-
rous structure frozen by simultaneous cooling. Initial
depressurization rate controlled by a back-pressure regula-
tor, and maximum cooling rate are significant parameters
that affect pore growth and stabilization. PLA/TCP and
PLA/HA scaffolds tested in vivo in this preliminary study
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were processed using the following parameters: 4.5 bar/s
and 4.48C/s.
In parallel, ChronOSTM scaffolds (b-TCP Mathys), made
of b-TCP, were tested (Mathys, Bettlach, Switzerland) and
scaffold morphology was evaluated by scanning electron
microscopy: porosity, pore size, anisotropy, and ceramic
distribution were verified (Fig. 1). Implanted volumes
were machined into cylinders (3 mm high, 8 mm diame-
ter), and sterilized by gamma irradiation (25 kGy).
Rat calvarial surgery
Rats were anesthetized using 2–3.5% isoflurane in oxy-
gen for *5 min in a small induction chamber using a
VMS anesthesia machine (MDS Matrx, Orchard Park, NY).
Once sedated, the animals were shaved and the cranial
surface sterilely prepared with alcohol. The animals were
placed on a heating pad to maintain body temperature
during the procedure. A midline incision (*3 cm long)
was made from the nasal bone to the crest using a surgical
blade. The soft tissue and the periosteum were elevated.
The craniotomy defect (8 mm) was created in the parietal
bone with a trephine drill (No. 207421, Provet SA, Lyssach,
Switzerland), under constant saline irrigation (Fig. 2) with
extreme care to preserve the underlying dura (Fig. 3). The
resulting defect was grafted with scaffolds made either of
PLA/TCP, PLA/HA, or b-TCP Mathys. The skin was
closed with stainless steel surgical clips. Postoperative an-
algesia was provided by subcutaneous injection of 0.03 mL
Butorphanol Morphasol1 (Dr. E. Gra¨ub AG, Bern, Switzer-
land). Following 12 days or 18 weeks after surgery, ani-
mals were sacrificed by CO2 asphyxiation. Craniotomy
sites with 5 mm neighboring bone were collected from the
skull and placed in 40% ethanol. Aseptic surgical tech-
nique was used throughout the procedure, and each condi-
tion was tested in triplicates.
Blood collection and leukocyte count
Directly after animal sacrifice, blood samples were col-
lected from heart puncture in EDTA-containing tubes
(Milian SA, Plan-les-Ouates, Switzerland). Total leukocyte
numbers were assessed using a counting chamber (Marien-
feld GmbH & Co. KG, Lauda-Koenigshofen, Germany),
following hemolysis of red blood cells in Turk’s solution
(0.01% crystal violet in 3% acetic acid). Differential counts
of white blood cells including lymphocytes, monocytes,
neutrophils, eosinophils, and basophils were determined
Figure 1. Scanning electron micrographs of scaffold structures. (A) PLA 5% b-TCP: porosity (83.4 6 2.5)%, pore diameter:
390 6 180 lm, modulus: 121.0 6 12.1 MPa. (B) PLA 5% HA: porosity (79.2 6 0.9)%, pore diameter: 400 6 250 lm, modu-
lus: 133.2 6 15.2 MPa. (C) b-TCP Mathys: porosity (75.4 6 0.3)%, pore diameter: 410 6 30 lm, modulus: 2.70 6 0.44 GPa.
Figure 2. Skull surgery. (A) Perforation of the parietal bone using a surgical trephine drill. (B) Implantation of a circular
bone substitute into the defect (8 mm diameter).
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morphologically from blood smears stained with Diff-
Quick (Dade Behring AG, Du¨dingen, Switzerland), yield-
ing results comparable with the Peppenheim technique.
Quantification of secreted cytokines
Plasma levels of proinflammatory cytokines IL6, TNF-a,
and IFN-g were measured using commercially available
ELISA kits according to the manufacturer’s instructions (BD
Biosciences Pharmingen, San Diego, CA). Blood samples
collected as described above were centrifuged for 10 min at
1000g and plasma was stored at "808C until analyses. Meas-
urements were made on 100 lL in triplicate for each sample.
Absorbance was recorded at 450 nm using a Wallac 1420
VICTOR2 multilabel plate reader (Wallac Oy, Turku, Fin-
land). The concentration of each cytokine was calculated
with reference to a standard curve that was constructed
using recombinant rat proteins provided in each kit.
Histological evaluation
After fixation in 10% buffered formalin, samples were
decalcified in 14% EDTA (pH 7.2) for 2 weeks at 378C and
during this period the solution was changed one time.
Specimens were then rinsed in PBS (pH 7.4) containing
6.8% sucrose overnight at 48C, and dehydrated in 100% ac-
etone during 60–90 min at 48C. Finally, they were embed-
ded in 2-hydroxyethylmethacrylate using infiltration and
embedding solutions (Technovit 8100, Heraus Kulzer
GmbH, Wehrheim, Germany). To evaluate the host tissue
response around the implants and to visualize bone forma-
tion, three sections of 3 lm thickness, and 1 mm distant
from each other were prepared and stained with hematox-
ylin and eosin (H&E by Gill). Sections were screened at
low power (403) to determine the capsule thickness. Three
measurements were taken on four sides of the scaffold
(periosteal (upper)/cerebral (lower)/right/left). Cell counts
Figure 3. Scanning electron micrograph showing the parietal bone (PB) and the dura mater (DM) exposed after the surgi-
cal intervention. Scale bar: 1 mm.
TABLE I
Scoring System for Host Tissue Reaction Evaluation
Fibrous Capsule Thickness Charaterization Host Cellular Response Cell Type Repartition
Grade Thickness Range (lm) Grade
Cells Counted on Each
Fibrous Capsule Section Grade Range (%)
0 0 0 0 0 0
1þ 1–30 1þ 1–60 1þ 1–5
2þ 31–150 2þ 61–300 2þ 6–25
3þ 151–300 3þ 301–600 3þ 26–50
4þ 301–450 4þ 601–900 4þ 51–75
5þ 451–600 5þ 901–1200 5þ 76–100
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within the fibrous tissue were assessed at high magnifica-
tion (4003). Three representative square sections of 0.250
mm side were analyzed on each border of the implant
using an ocular grid. Different cells including neutrophils,
foreign body giant cells (FBGC), lymphocytes, macro-
phages, and fibroblasts were determined morphologically.
Mean values were calculated for each section and then for
each implant. Tissue reaction was appraised by the
method described by Black,44 and adapted from earlier
studies.45–47 Briefly, capsular thickness, cellular response
and cell type repartitions were evaluated, and scores from
0 to 5þ were attributed according to the criteria given in
Table I. An overall rating was obtained using weighting
factors (53 for the capsular thickness, 33 for the cellular
response observed in the capsule, 53 for the neutrophils,
23 for the FBGCs, 13 for the lymphocytes, 13 for macro-
phages, and 13 for the fibroblasts). Reactions were classi-
fied into 6 categories, which were as follows: no reaction
(0), minimal (1–10), slight (11–25), moderate (26–40),
marked (41–60), and excessive (>60).
Scanning electron microscopy
Samples were rinsed with PBS (Invitrogen, Carlsbad,
CA) prior to fixation with primary glutaraldehyde fixative:
0.1M sodium cacodylate (Polysciences, Warrington, PA),
5% glutaraldehyde (Polysciences), 0.1M sucrose (Axon Lab
AG, Baden-Da¨twill, Switzerland), pH 7.4, for 45 min at
48C. The fixative was then replaced by a buffered sucrose
vehicle: 0.1M sodium cacodylate, 0.1M sucrose, pH 7.4, for
30 min at 48C. After this step, bones were placed in os-
mium fixative: 0.1M sodium cacodylate, 0.1M sucrose, 1%
osmium tetroxyde (Polysciences), pH 7.4, for 60 min at
48C. Samples were washed twice at room temperature
with demineralized water before dehydration and air-dry-
ing from a solution of hexamethyldisilazane (Polysciences).
The sample surfaces were gold-coated during 2 min under
1 kV and observed using a scanning electron microscope
Philips XL30 (FEI, Hillsboro, OR) at a voltage of 5 kV.
Radiography of rat specimen
The presence of newly formed bone was determined
radiographically. Skulls were placed with the exocranial
surfaces on top of a radiographic cassette (High Resolution
Storage Phosphor Screen CR Cassette, Kodak, Rochester,
NY) at a standardized distance of 125 cm from the X-ray
head (10 mAs, 50 kV). Samples were imaged and pro-
cessed with image analysis software (ImageJ, Wayne Ras-
band, National Institutes of Health, Bethesda, MD). Histo-
grams were identified on the digitized radiographs in each
defect area after adjustment of the background to zero.
Statistical analysis
For this study, 24 animals were randomly assigned to
the different groups, including the sham surgery rats and
all conditions were tested in triplicate. Evaluations were
performed in a blind manner when analyzing the treat-
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ments of the defects. Results are presented as mean values
with associated standard errors of the mean.
RESULTS
Body weights
The evolution of body weights was similar in all
groups during this study (data not shown). The
implants tested showed no effect on this variable,
compared to the sham operated animals.
Haematology
Total and differential leukocyte cell counts were
alike in all implanted groups at the two time points
(12 days and 18 weeks after the surgery), and are
summarized in Table II. No difference was noticed
compared with the sham group. A slight decrease of
leukocyte cell numbers was observed between day
12 and week 18 within each group. Systemic concen-
trations of proinflammatory cytokines IL6 and TNF-
a were measured and values are reported in Table
II. During the experiment, plasma levels of these
proteins remained stable and no marked variation
between groups was observed, whereas IFN-g was
not detectable.
Histology
Rating of the overall host tissue response of each
scaffold is presented at both time points in Table III.
After 12 days in vivo, marked to moderate inflamma-
tory responses were observed. This assessment was
then attenuated with time of exposure with moder-
ate to slight reactions noticed at week 18. In more
detail at day 12, PLA/TCP implants were covered
with a layer of approximately 2–3 cells in thickness
(consisting predominantly of macrophages), and sur-
rounded by loose connective tissue with an adjacent
capillary network. PLA/HA composites induced a
comparable host-tissue reaction, whereas superficial
host-tissue infiltration was observed within b-TCP
Mathys inserts [Fig. 4(A–C)]. Macrophages and mul-
tinucleated giant cells were seen in the proximity of
the fragments coming from these scaffolds. The pres-
ence of particles detached from b-TCP Mathys
implants was noticed along with FBGCs at a higher
frequency within this group, compared to the PLA/
ceramic groups [Fig. 4(D–F)]. At this early time
point, lamellar bone deposition was observed in all
groups between the old bone and the dura mater, as
well as around the trephine margins [Fig. 4(G–I)].
Active osteoblasts were present on the surface of the
new bone matrix and within forming osteons. Only
a few osteoclasts were located at this site of intense
bone modeling. At the end of the study, the vault of
the cranium was restored in one animal out of three
within each of the PLA/TCP and PLA/HA groups
(Fig. 5). Bone was formed predominantly at the cere-
bral (lower) side of the implants, but also on the lat-
eral and periosteal (upper) sides. In the other ani-
mals from these treatment groups a clear reduction
of the original defect size was detected. Albeit the
healing process in b-TCP Mathys scaffolds was less
TABLE III
Histological Semiquantative Evaluation of Host Tissue Reaction
Cells Present in the Fibrous Capsule
Group
Time
(weeks)
Capsule
Thickness
Cellular
Response Neutrophils FBGC Lymphocytes Macrophages Fibroblasts
Response
Evaluation
PLA/TCP 12/7 3þ 5þ 2þ 0 0 1þ 4þ Marked (45þ)
12/7 4þ 5þ 2þ 0 0 2þ 4þ Marked (51þ)
12/7 4þ 4þ 2þ 0 0 2þ 5þ Marked (49þ)
18 3þ 3þ 1þ 0 1þ 2þ 5þ Moderate (37þ)
18 2þ 2þ 0 0 0 2þ 5þ Slight (23þ)
18 3þ 3þ 1þ 0 0 2þ 5þ Moderate (36þ)
PLA/HA 12/7 4þ 4þ 2þ 0 0 2þ 4þ Marked (48þ)
12/7 3þ 3þ 1þ 0 0 2þ 5þ Moderate (36þ)
12/7 4þ 4þ 1þ 0 0 3þ 4þ Marked (44þ)
18 2þ 2þ 0 0 0 2þ 5þ Slight (23þ)
18 3þ 3þ 1þ 0 1þ 2þ 4þ Moderate (36þ)
18 4þ 2þ 1þ 0 0 2þ 5þ Moderate (38þ)
bTCP Mathys 12/7 3þ 3þ 2þ 1þ 0 2þ 4þ Marked (42þ)
12/7 4þ 3þ 1þ 1þ 0 3þ 4þ Marked (43þ)
12/7 5þ 5þ 1þ 0 0 2þ 5þ Marked (52þ)
18þ 4þ 4þ 0 0 0 2þ 5þ Moderate (39þ)
18 3þ 4þ 1þ 0 0 2þ 5þ Moderate (39þ)
18 5þ 4þ 2þ 0 0 2þ 5þ Marked (54þ)
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advanced at this time point, ossification was ob-
served in many pores of its structure. In the sham
group, the cavity was mainly covered with fibrous
tissue and bone formation occurring only along the
defect margin and this is consistent with the model
of CSD.
Radiography of rat specimen
In addition, the presence of newly formed bone
was confirmed radiographically (Fig. 6). An increase
in the area of radio-opacity representing new bone
formation was observed within the skull defects
between day 12 and week 18 for the PLA/TCP and
PLA/HA implants. Because of the high radiopacity
of the b-TCP Mathys scaffold, bone formation was
not easily detected by X-ray in this group, leading to
a possible underestimation of the healing process,
whereas no new bone formation occurred in the
sham group.
DISCUSSION
The aim of this study was to test in vivo the bio-
compatibility and osteoconductivity of ceramic-rein-
forced PLA scaffolds obtained by supercritical gas
foaming. The CSD craniotomy model was chosen for
this purpose. A key finding was the observation of
complete bone bridging 18 weeks after implantation
of PLA porous structures.
First, we evaluated the host-tissue reaction after
implantation. Local inflammatory reaction assessed
after implanting polymers can be divided into three
main phases: acute (0–7 days), subacute (7–28 days),
and chronic (>28 days).46 What is seen in general are
polymorphonuclear leukocytes manifesting in early
Figure 4. Photomicrographs of histological representative sections at 12 days after the implantation of PLA/TCP (right),
PLA/HA (middle), and b-TCP Mathys (left). (A–C) Fibrous capsule. (D–F) Localization of foreign body giant cells. (G–I)
Edge from the defect. Abbreviations and signs used: foreign body giant cells (FBGC) indicated with arrows; new bone
(NB); old bone (OB); implant localization (*). Hematoxylin and eosin stain. Scale bars: (A–C) 200 lm, (D–F) 20 lm, (G–I)
100 lm. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
REPAIR OF CRITICAL SIZE DEFECTS IN THE RAT CRANIUM 47
Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
inflammation, attracted by chemokines released by
damaged cells.48 In the subacute phase, monocytes,
macrophages, and fibroblasts predominate, leading
to the formation of a dense fibrous tissue, mainly
consisting of fibroblasts and collagen matrix.49 The
chronic phase is characterized by increased polymer
degradation, few macrophages or giant cells, and fi-
brous encapsulation.50 Our observations are in ac-
cordance with these descriptions. In the present
study, the host-tissue reaction was semiquantitatively
evaluated, leading to similar results in the different
treatment groups. Although highly reactive in all
group tested, the response did regress with time to
reach a moderate grade. This was principally due to
the decreased fibrous capsule thickness and cellular
content. The dense cell layer found 12 days after im-
plantation could be due to the surgical trauma com-
bined with an initial foreign body reaction. Systemic
concentrations of IL6 and TNF-a were comparable
with values reported in literature.51 Polymer resorp-
tion was apparent at the latest sacrifice, as fragments
were observed within the new bone and the soft tis-
sues but no sign of necrosis was noted.
Second, we characterized the ability of the struc-
tures to guide osteoprogenitor cells leading to new
bone formation. Morphologically and embriologi-
cally, the calvaria develops from a membrane pre-
cursor and thus resembles the membranous bones of
the face, whereas bones that form the base of the
skull display endochondral ossification. Intramem-
branous ossification is characterized by the direct
mineralization of a highly vascular connective tissue
membrane. Analysis of the early events in the heal-
ing process indicates that new bone is generated
mainly from the surface of the dura mater at the
base of the defect, as well as from the periosteum
Figure 5. Histologic assessment of bone regeneration at 18 weeks. Three calvarial defects were analyzed for each group
in 3 lm sections stained with hematoxylin and eosin. Composite photomicrographs were assembled from histological sec-
tions closest to the center of the defects. Best healing responses are presented for each group: detailed cranial vaults (left)
and general view of the implants (right). [Color figure can be viewed in the online issue, which is available at www.
interscience.wiley.com.]
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and perhaps—in a lesser measure—at the edges
from the old bone. In this study, the thin trabeculae
of the early bone were found to progress into a scat-
tered network, which enclosed blood vessels forming
primary osteonal systems. Corroborating these obser-
vations, trephine defects were shown to heal not
only by ingrowth from the rim but also by prolifera-
tion of perivascular mesenchymal-type cells of the
dura mater.24 In the first few days of bony healing,
cells are migrating, attaching, and differentiating
into osteoblasts to propagate bone growth.2 Thus,
during this time, rigid fixation was important so that
the stability of the implant can assure adequate con-
trol of experimental variables. In this preliminary
study using only a small number of animals because
of ethical reasons, we were able to appropriately
choose time points and evaluation conditions. Even
though the limitation of animal numbers did not
allow statistical comparison of the X-ray data the
values obtained were used to support the qualitative
Figure 6. Roentgenograms of cranial trephine defects in adult rat skulls. The exocranial surfaces were exposed on top of
a radiographic cassette (High Resolution Storage Phosphor Screen CR Cassette, Kodak, Rochester, NY) at a distance of 125 cm
from the X-ray head (10 mAs, 50 kV). Samples were imaged and processed with an image analysis software (ImageJ,
Wayne Rasband, National Institutes of Health, Bethesda, MD). Histograms of the defect area were generated from digi-
tized radiographs with background adjusted to zero. X-rays were taken 12 days (A) and 18 weeks (B) after the surgical
intervention. Representative images and corresponding histogram analyses are shown.
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bone repair description in each implant group. Clear
healing of the cranial defects treated with the PLA/
ceramic structures was observed by histology and
confirmed by radiography.
CONCLUSIONS
The biocompatibility of PLA/ceramic foams was
assessed in terms of inflammatory host response and
fibrous capsule formation. Histological evaluation
showed a marked but local and temporary restricted
reaction. Moreover, the granulation tissue surround-
ing the implants was a foreign body reaction consist-
ing mainly of macrophages, fibroblasts, and capilla-
ries. No chronic inflammation was induced, as lym-
phocytes and eosinophils were rarely present in the
close neighborhood of the constructs. The encoun-
tered FBGC were principally located around particu-
late materials detached from b-TCP scaffolds. Using
shearing mechanical stimulations in vitro, PLA com-
posites showed no apparent erosion due to their ho-
mogeneity, whereas pure b-TCP implants displayed
scattered debris (data not shown). We conclude that
PLA/ceramic architectures obtained by melt-extru-
sion coupled with supercritical gas foaming offer
suitable conditions for host tissue integration. Fur-
thermore, a complete reconstruction of the cranial
vault was observed with the porous architecture of
PLA/ceramic constructs. Thus, their osteoconductive
properties previously described in vitro1 are con-
firmed in vivo as assessed by histology and radiogra-
phy. On the basis of these promising results, further
studies using the CSD craniotomy model with a
larger sample size will be undertaken. Parallely, the
same scaffolds will be integrated in long bones at
the immediate vicinity of bone marrow and blood
supply. This new approach to create composite
structures is promising for tissue engineering, espe-
cially for applications in maxillofacial bone repair
and during revision of total joint replacement.
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